Table I.
Baseline characteristics of newly diagnosed patients with AML (cohort 1).
| Total number of patients | n = 52 |
|---|---|
| Median age (years, range) | 75 (45–91) |
| Percent ≥ 80 years | 25 |
| M/F (%) | 44/56 |
| ECOG performance status (%) | |
| 0 | 19 |
| 1 | 46 |
| 2 | 23 |
| 3 | 8 |
| 4 | 4 |
| Cytogenetics (%) | |
| Adverse | 35 |
| Intermediate | 65 |
| Baseline WBC, × 109/L (%) | |
| < 10 | 65 |
| ≥ 10 | 35 |
| Baseline bilirubin (%) | |
| ≤ 1.3 | 81 |
| > 1.3 | 19 |
| Baseline creatinine (%) | |
| ≤ 1.3 | 81 |
| > 1.3 | 19 |
AML, acute myeloid leukemia; M/F, male/female; ECOG, Eastern Cooperative Oncology Group; WBC, white blood cell count.